Indications and uses
Homeopathic guidelines indicate these drops to relieve dryness and irritation related to wearing Ortho-K lenses at night.
Homeopathic guidelines indicate these drops to relieve dryness and irritation related to wearing Ortho-K lenses at night.
Instill one drop on each Ortho-K lens before and after insertion for the night.
- Store at room temperature.
| Euphrasia (Eyebright) | 6x | General dryness, redness and irritation of the eye and lids |
| Alumina | 12x | Dryness of the eyes and other mucous membranes |
| Arsenicum album | 8x | Severe dryness |
| Apis | 6x & 12x | Pain, redness, edema, allergies |
| Calcarea phosphorica | 12X | Foreign body sensation |
| Staphysagria | 6x & 12x | Foreign body sensation |
| Sulphur | 7x | Dryness, redness of eye and lid, allergies |
| Calendula | 7x | Corneal healing/vitality |
| Euphrasia (Eyebright) | 6x |
| Alumina | 12x |
| Arsenicum album | 8x |
| Apis | 6x & 12x |
| Calcarea phosphorica | 12X |
| Staphysagria | 6x & 12x |
| Sulphur | 7x |
| Calendula | 7x |
| Calcium chloride |
| Magnesium chloride |
| Sodium chloride |
| Potassium chloride |
| Purified water |
| Boric acid |
| Oxychloro complex |
| Sodium borate |
Homeopathic guidelines indicate these drops to relieve dryness and irritation related to wearing Ortho-K lenses at night.
Instill one drop on each Ortho-K lens before and after insertion for the night.
- For ophthalmic use only.
- If you experience eye pain, changes in vision, continued redness or irritation of the eye, or if the condition worsens or persists for more than 72 hours, discontinue use and consult a doctor.
- For Professional Use Only
Keep out of reach of children.
- Store at room temperature.
Natural Ophthalmics, Inc
Dillon, CO, 80435
1-877-220-9710
www.natoph.com
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 68770-143-07 | 2025-12-23 | C162847 | 48780-1 | 97449f38-c146-f6ea-e053-dbdaa90aa703 | Ortho-K Thick (Night) |
| 68770-143-07 | 2022-01-28 | C162847 | 48780-1 | 97449f38-c146-f6ea-e053-dbdaa90aa703 | Ortho-K Thick (Night) |
| 68770-143-07 | 2019-12-20 | C162847 | 48780-1 | 97449f38-c146-f6ea-e053-dbdaa90aa703 | Ortho-K Thick (Night) |
| 68770-143-07 | 2019-11-13 | C162847 | 48780-1 | 97449f38-c146-f6ea-e053-dbdaa90aa703 | Ortho-K Thick (Night) |
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 68770-143 | ORTHO-K THICK (NIGHT) (EUPHRASIA STRICTA, ALUMINUM OXIDE, ARSENIC TRIOXIDE, APIS MELLIFERA, TRIBASIC CALCIUM PHOSPHATE, DELPHINIUM STAPHISAGRIA SEEDS, SULPHUR, CALENDULA OFFICINALIS FLOWERING TOP) LIQUID [NATURAL OPHTHALMICS, INC] | 2 | Legacy NDC | 20191221_92fbbc98-0e4b-471d-8a0e-4b9b14ddbcc7.zip |
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| Aluminum Oxide | ACTIVE INGREDIENT | LMI26O6933 | 1 | |
| Apis mellifera | ACTIVE INGREDIENT | 7S82P3R43Z | 1 | |
| Arsenic Trioxide | ACTIVE INGREDIENT | S7V92P67HO | 1 | |
| Calendula Officinalis Flowering Top | ACTIVE INGREDIENT | 18E7415PXQ | 1 | |
| Delphinium Staphisagria Seed | ACTIVE INGREDIENT | 00543AP1JV | 1 | |
| Euphrasia Stricta | ACTIVE INGREDIENT | C9642I91WL | 1 | |
| Sulfur | ACTIVE INGREDIENT | 70FD1KFU70 | 1 | |
| Tribasic Calcium Phosphate | ACTIVE INGREDIENT | 91D9GV0Z28 | 1 | |
| Aluminum Oxide | ACTIVE MOIETY | LMI26O6933 | 1 | |
| Apis mellifera | ACTIVE MOIETY | 7S82P3R43Z | 1 | |
| Arsenic Trioxide | ACTIVE MOIETY | S7V92P67HO | 1 | |
| Calcium Cation | ACTIVE MOIETY | 2M83C4R6ZB | 1 | |
| Calendula Officinalis Flowering Top | ACTIVE MOIETY | 18E7415PXQ | 1 | |
| Delphinium Staphisagria Seed | ACTIVE MOIETY | 00543AP1JV | 1 | |
| Euphrasia Stricta | ACTIVE MOIETY | C9642I91WL | 1 | |
| Sulfur | ACTIVE MOIETY | 70FD1KFU70 | 1 | |
| Boric acid | INACTIVE INGREDIENT | R57ZHV85D4 | 1 | |
| Calcium chloride | INACTIVE INGREDIENT | M4I0D6VV5M | 1 | |
| Magnesium chloride | INACTIVE INGREDIENT | 02F3473H9O | 1 | |
| Potassium chloride | INACTIVE INGREDIENT | 660YQ98I10 | 1 | |
| Sodium borate | INACTIVE INGREDIENT | 91MBZ8H3QO | 1 | |
| Sodium chloride | INACTIVE INGREDIENT | 451W47IQ8X | 1 | |
| Sodium Chlorite | INACTIVE INGREDIENT | G538EBV4VF | 1 | |
| Water | INACTIVE INGREDIENT | 059QF0KO0R | 1 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 68770-143 | 68770-143-07 |
Every source-derived ingredient row is available through these pages.
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| Sodium chloride | SODIUM CHLORIDE | 451W47IQ8X | POWDER, FOR SUSPENSION / ENDOTRACHEAL | 46.76 mg | ||
| Sodium chloride | SODIUM CHLORIDE | 451W47IQ8X | INJECTION / SUBCUTANEOUS | 1486 mg | ||
| Sodium chloride | SODIUM CHLORIDE | 451W47IQ8X | INJECTION / INTRA-ARTERIAL | 278 mg | ||
| Calcium chloride | CALCIUM CHLORIDE | M4I0D6VV5M | CONCENTRATE / ORAL | 0.08 mg/1ml | ||
| Sodium chloride | SODIUM CHLORIDE | 451W47IQ8X | INJECTION, SOLUTION / EPIDURAL | 3535 mg | ||
| Sodium borate | SODIUM BORATE | 91MBZ8H3QO | EMULSION / OPHTHALMIC | 0.11 %w/v | ||
| Calcium chloride | CALCIUM CHLORIDE | M4I0D6VV5M | INJECTION, SUSPENSION / INTRAVITREAL | 0.05 %w/v | ||
| Magnesium chloride | MAGNESIUM CHLORIDE | 02F3473H9O | SOLUTION / OPHTHALMIC | 0.01 %w/v | ||
| Sodium borate | SODIUM BORATE | 91MBZ8H3QO | SUSPENSION/ DROPS / OPHTHALMIC | 0.03 %w/w | ||
| Sodium chloride | SODIUM CHLORIDE | 451W47IQ8X | INJECTION, SOLUTION / SUBMUCOSAL | 16 %w/v | ||
| Sodium borate | SODIUM BORATE | 91MBZ8H3QO | SOLUTION / OPHTHALMIC | 2 mg | ||
| Boric acid | BORIC ACID | R57ZHV85D4 | MOUTHWASH / BUCCAL | 7.36 mg/1ml | ||
| Boric acid | BORIC ACID | R57ZHV85D4 | SUSPENSION/ DROPS / AURICULAR (OTIC) | 3 mg | ||
| Boric acid | BORIC ACID | R57ZHV85D4 | INJECTION, SOLUTION / INTRAVENOUS | 210 mg | ||
| Sodium chloride | SODIUM CHLORIDE | 451W47IQ8X | INJECTION, SOLUTION, CONCENTRATE / INTRAMUSCULAR | 0.86 %w/v | ||
| Potassium chloride | POTASSIUM CHLORIDE | 660YQ98I10 | TABLET / ORAL | 231 mg | ||
| Sodium chloride | SODIUM CHLORIDE | 451W47IQ8X | INJECTION / INTRAVENOUS | 28773 mg | ||
| Sodium chloride | SODIUM CHLORIDE | 451W47IQ8X | INJECTION / PERIDURAL | 8.07 mg | ||
| Sodium chloride | SODIUM CHLORIDE | 451W47IQ8X | INJECTION, EMULSION / INTRAVENOUS | 0.62 %w/v | ||
| Sodium chloride | SODIUM CHLORIDE | 451W47IQ8X | SOLUTION / INTRAVASCULAR | NA | ||
| Sodium chloride | SODIUM CHLORIDE | 451W47IQ8X | SUSPENSION / SUBCUTANEOUS | 0.8 %w/v | ||
| Calcium chloride | CALCIUM CHLORIDE | M4I0D6VV5M | INJECTION / INTRAMUSCULAR | 4 %w/v | ||
| Sodium chloride | SODIUM CHLORIDE | 451W47IQ8X | SOLUTION/ DROPS / AURICULAR (OTIC) | 18 mg | ||
| Sodium borate | SODIUM BORATE | 91MBZ8H3QO | CREAM / TOPICAL | NA | ||
| Calcium chloride | CALCIUM CHLORIDE | M4I0D6VV5M | SOLUTION/ DROPS / OPHTHALMIC | 0.02 %w/v | ||
| Sodium chloride | SODIUM CHLORIDE | 451W47IQ8X | INJECTION / INTRAVITREAL | 10 %w/v | ||
| Potassium chloride | POTASSIUM CHLORIDE | 660YQ98I10 | POWDER / RESPIRATORY (INHALATION) | 0.18 mg | ||
| Sodium chloride | SODIUM CHLORIDE | 451W47IQ8X | CREAM / TOPICAL | 0.4 %w/w | ||
| Sodium chloride | SODIUM CHLORIDE | 451W47IQ8X | INJECTION / INTRACAVITARY | 0.82 %w/v | ||
| Sodium chloride | SODIUM CHLORIDE | 451W47IQ8X | TABLET, FILM COATED / ORAL | 100 mg | ||
| Sodium chloride | SODIUM CHLORIDE | 451W47IQ8X | INJECTION, SOLUTION / PARENTERAL | 210 mg | ||
| Calcium chloride | CALCIUM CHLORIDE | M4I0D6VV5M | CAPSULE / ORAL | 2 mg | ||
| Boric acid | BORIC ACID | R57ZHV85D4 | EMULSION / TOPICAL | 1.3 %w/w | ||
| Magnesium chloride | MAGNESIUM CHLORIDE | 02F3473H9O | SOLUTION / INTRAPERITONEAL | 0.01 %w/v | ||
| Sodium chloride | SODIUM CHLORIDE | 451W47IQ8X | SOLUTION / AURICULAR (OTIC) | 18 mg | ||
| Boric acid | BORIC ACID | R57ZHV85D4 | SOLUTION, GEL FORMING, EXTENDED RELEASE / OPHTHALMIC | 0.3 %w/w | ||
| Sodium chloride | SODIUM CHLORIDE | 451W47IQ8X | SUPPOSITORY / RECTAL | 140 mg | ||
| Sodium chloride | SODIUM CHLORIDE | 451W47IQ8X | SUSPENSION / INTRATYMPANIC | 2 mg | ||
| Potassium chloride | POTASSIUM CHLORIDE | 660YQ98I10 | SUSPENSION / ORAL | NA | ||
| Boric acid | BORIC ACID | R57ZHV85D4 | SUSPENSION/ DROPS / TOPICAL | 0.3 %w/v | ||
| Sodium chloride | SODIUM CHLORIDE | 451W47IQ8X | INJECTION, POWDER, FOR SOLUTION / INTRAVENOUS | 2922 mg | ||
| Sodium chloride | SODIUM CHLORIDE | 451W47IQ8X | INJECTION / SUBMUCOSAL | 17 mg | ||
| Boric acid | BORIC ACID | R57ZHV85D4 | SHAMPOO / TOPICAL | 2 %w/w | ||
| Sodium chloride | SODIUM CHLORIDE | 451W47IQ8X | INJECTION / INTRATHECAL | 9 mg | ||
| Sodium chloride | SODIUM CHLORIDE | 451W47IQ8X | POWDER / TOPICAL | NA | ||
| Sodium chloride | SODIUM CHLORIDE | 451W47IQ8X | POWDER, DENTIFRICE / DENTAL | 0.03 mg/mg | ||
| Sodium chloride | SODIUM CHLORIDE | 451W47IQ8X | SOLUTION / NASAL | 330 mg | ||
| Sodium chloride | SODIUM CHLORIDE | 451W47IQ8X | SUSPENSION / INTRAMUSCULAR | 9 mg | ||
| Sodium chloride | SODIUM CHLORIDE | 451W47IQ8X | SUSPENSION/ DROPS / OPHTHALMIC | 3 mg | ||
| Sodium chloride | SODIUM CHLORIDE | 451W47IQ8X | TABLET, COATED / ORAL | 54.7 mg | ||
| Boric acid | BORIC ACID | R57ZHV85D4 | JELLY / VAGINAL | 1 %w/w | ||
| Sodium chloride | SODIUM CHLORIDE | 451W47IQ8X | SOLUTION / INTRAPERITONEAL | 0.54 %w/v | ||
| Potassium chloride | POTASSIUM CHLORIDE | 660YQ98I10 | INJECTION / INTRAVENOUS | 1 mg | ||
| Sodium chloride | SODIUM CHLORIDE | 451W47IQ8X | SUSPENSION/ DROPS / TOPICAL | 0.23 %w/v | ||
| Sodium chloride | SODIUM CHLORIDE | 451W47IQ8X | TABLET / ORAL | 231 mg | ||
| Sodium chloride | SODIUM CHLORIDE | 451W47IQ8X | SOAP / TOPICAL | 1.26 %w/w | ||
| Sodium chloride | SODIUM CHLORIDE | 451W47IQ8X | INJECTION, SOLUTION / SUBCUTANEOUS | 1486 mg | ||
| Sodium chloride | SODIUM CHLORIDE | 451W47IQ8X | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRAMUSCULAR | 360 mg | ||
| Potassium chloride | POTASSIUM CHLORIDE | 660YQ98I10 | INJECTION, SOLUTION / INTRAVENOUS | 330 mg | ||
| Boric acid | BORIC ACID | R57ZHV85D4 | SOLUTION/ DROPS / OPHTHALMIC | 48 mg |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 46aa6d3e-b7b8-11a6-e063-6394a90a3cc8 | 92fbbc98-0e4b-471d-8a0e-4b9b14ddbcc7 | 2025-12-23 | Warnings | 92fbbc98-0e4b-471d-8a0e-4b9b14ddbcc7 |
Adverse event summaries are temporarily unavailable. Other product information remains available.